Dr. Safirstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
911 E Hallandale Beach Blvd
Hallandale Beach, FL 33009Phone+1 954-455-5757- Is this information wrong?
Summary
- Dr. Beth Safirstein is a Board Certified Neurologist in Hallandale Beach, FL. She received her medical degree from Indiana University School of Medicine, trained at University of Miami/Jackson Memorial Hospital and has been in practice 24 years. She is experienced in sleep medicine, Alzheimer's Disease, Parkinson's Disease, non-alcoholic fatty liver disease, Schizophrenia, Bipolar Disorder, Major Depressive Disorder, Vaccine clinical trials, Pharmacokinetic trials, Pharmacodynamic trials, and obesity and obesity-related disorders. She has more than 30 publications and over 500 citings.
Education & Training
- Indiana University School of MedicineClass of 1996
- Indiana UniversityB.A., 1988 - 1992
Certifications & Licensure
- FL State Medical License 1999 - 2025
- American Board of Psychiatry and Neurology Neurology
- National Board of Physicians and Surgeons Neurology
Awards, Honors, & Recognition
- Conference Educational Grant American Academy of Neurology, 2000
- Strathmore's WHO's WHO 2000
- George Paff Teaching Award University of Miami School of Medicine, 1998
- Join now to see all
Clinical Trials
- Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease Start of enrollment: 2008 Oct 01
- Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 Start of enrollment: 2010 May 01
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.Werner, M., McGarry, A., Meyer, C., Kruger, S., Klint, C., Pellecchia, J., Walaker, S., Ereshefsky, L., Blob, L., Hassman, H., Rodriguez, C., Samara, E., Olanow, C., S...> ;Journal of Parkinson's Disease. 2024 Jan 1
- Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function ...Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA, Alzheimer’s Disease Cooperative Study> ;JAMA neurology.
- Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M, NAC-MD-01 Study Investigators> ;Lancet (London, England).
- Join now to see all
Journal Articles
- Successful treatment of hemichorea with olanzapineBeth Safirstein, MD, Lisa Shulman, MD, and William Weiner, MD, Movement Disorders, 1/23/2001
Abstracts/Posters
- Rivastigmine and Concomitant Memantine in Alzheimer's Disease: Safety and TolerabilityBeth Safirstein, Xiangyi Meng, Jason T. Olin, CNS Spectr, 1/1/2010
- Lamotrigine for Treatment of Pain Associated with Diabetic Neuropathy: Results of two randomized, double-blind, placebo-controlled studiesVinik Al et al, Pain, 1/1/2006
- AX-PC-003 Phenserine in patients with Alzheimer's DiseaseSafirstein BE, Neurology
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: